Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • CRF Bracket Welcomes Susie Robinson as Chief People Officer

    Mar 7, 2019, 09:14 AM by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Mar 7, 2019 - CRF Bracket today announced that Susie Robinson will join the company as Chief People Officer. Susie brings to CRF Bracket more than two decades of human resources leadership with an impressive track record of success as a global HR executive
    Full story
  • TraceLink Announces Smart Inventory Tracker, an End-to-End Warehouse Compliance Solution Built on its Integrated Digital Supply Network Platform

    Mar 7, 2019, 04:32 AM by Michael Croft
    , MA - Mar 7, 2019 - North Reading, Mass. (March 5, 2019)-TraceLink Inc., the world's largest integrated digital supply network providing real-time information sharing for better patient outcomes, today announced Smart Inventory Tracker, a cloud-based end-to-end warehouse compliance solution offered within its integrated digital supply network
    Full story
  • The Pistoia Alliance Launches MethodDB Project to Tackle Lab Inefficiency and Support AI Adoption

    Mar 7, 2019, 03:40 AM by Michael Croft
    BOSTON, MA, UNITED STATES - Mar 7, 2019 - The Pistoia Alliance, a global not-for-profit that works to lower barriers to innovation in life sciences R&D, today released proof of concept (PoC) software to enable the digitisation of analytical method descriptions, as part of its Method Database (MethodDB) project
    Full story
  • Latest Genetic Map Finds Recombination Is Not So Random

    Mar 6, 2019, 10:15 AM by Michael Croft
    Bio-IT World  The latest genetic map published by Reykjavík, Iceland-based deCODE Genetics may well be the last, according to CEO and founder Kári Stefánsson. The high-resolution map of human recombination—which uses whole-genome sequence (WGS) data on nearly 130,000 people—is about as good as it can theoretically get, he says.
    Full story
  • BioIVT Launches Its XPRESSWAY® Profile Safety Package, a Gene Expression Reference Guide Designed to Improve Drug Safety Analyses

    Mar 6, 2019, 08:11 AM by Michael Croft
    WESTBURY, NY - Mar 6, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the launch of its XPRESSWAY Profile Safety Package, a compendium of 46 gene expression profiles for genes known to play pivotal roles in drug safety assessments
    Full story
  • Newcastle Hospitals Improve Patient Recruitment with CLiX Software

    Mar 6, 2019, 07:47 AM by Michael Croft
    LONDON, UNITED KINGDOM - Mar 6, 2019 - Following the successful conclusion of a pilot study, Clinithink's CLiX software is now being used by the Newcastle upon Tyne Hospitals NHS Foundation Trust - one of the UK's leading clinical research centres - to improve patient recruitment in their clinical trialsx
    Full story
  • Boost for Life Sciences with partnership between UK’s OptiBiotix Health and Zeon Lifesciences

    Mar 6, 2019, 05:51 AM by Michael Croft
    - Mar 6, 2019 - British company Optibiotix has signed an exclusive manufacturing and supply agreement with Indian Healthcare company Zeon for the use of OptiBiotix’s science-based weight management technology, SlimBiome®
    Full story
  • Menarini Silicon Biosystems Develops New Assay Workflow for Circulating Multiple Myeloma Cells

    Mar 5, 2019, 10:46 AM by Michael Croft
    HUNTINGDON VALLEY, PA, UNITED STATES - Mar 5, 2019 -   Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, announced today that it will introduce a new semi-automated assay workflow utilizing the CELLSEARCH® and DEPArrayTM platforms to enumerate and characterize circulating multiple myeloma cells (CMMC) from peripheral blood samples
    Full story
  • Centers for Disease Control and Prevention (CDC) Selects Certara to Develop Technology Platform to Strengthen the Agency’s Death Investigation and Surveillance Systems

    Mar 5, 2019, 10:14 AM by Michael Croft
    PRINCETON, NJ - Mar 5, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that the US Centers for Disease Control & Prevention (CDC) has awarded it a contract to strengthen the Agency’s death investigation and surveillance systems
    Full story
  • Procarta announces €1.5 million investment for new class of antibiotics to combat antimicrobial resistance

    Mar 5, 2019, 05:04 AM by Michael Croft
    STEVENAGE, UK - Mar 5, 2019 - Procarta Biosystems, a privately held UK-based biotech company, today announced €1.5m of new funding from the Novo Holdings REPAIR Impact Fund to support development of novel therapies to combat antimicrobial resistance (AMR)
    Full story
  • BOC Sciences Has Updated Its API Synthesis by Joining Intermediates Synthesis Service

    Mar 4, 2019, 01:19 AM by Michael Croft
    SHIRLEY, NY - Mar 4, 2019 - BOC Sciences, a US-based global manufacturer of high-quality chemicals and efficient custom services to support the pharmaceutical industry through all stages of drug discovery, has recently added intermediates synthesis to its API synthesis portfolio
    Full story
  • BINDING SITE OFFERS NATIVE BORDETELLA PERTUSSIS ANTIGENS FOR RESEARCH & IVD MANUFACTURING APPLICATIONS

    Mar 1, 2019, 14:50 PM by Michael Croft
    SAN DIEGO, CA - Mar 1, 2019 - BINDING SITE'sImmunologicals Group is pleased to announce the addition of three (3) new native Bordetella pertussis antigens to its broad offering of products for in-vitro diagnostic (IVD) manufacturing and research applications
    Full story
  • Recipharm achieves new ISO 45001 certification to support sustainability efforts

    Mar 1, 2019, 09:44 AM by Michael Croft
    - Mar 1, 2019 - Recipharm, the contract development and manufacturing organisation (CDMO), has achieved the new ISO 45001 certification at its Wasserburg facility in Germany
    Full story
  • Creative Biolabs Releases One-stop Vaccine Development Services

    Feb 28, 2019, 05:09 AM by Michael Croft
    SHIRLEY, NY - Feb 20, 2019 - As a leading service provider that focuses on vaccines fields, Creative Biolabs now releases comprehensive one-stop vaccine development services to help researchers and vaccine companies to reduce the cost of failure and increase the chance of clinical success
    Full story
  • Rare disease repurposing datathon from Elsevier and The Pistoia Alliance reveals five new candidates for potential treatment of chronic pancreatitis

    Feb 28, 2019, 04:03 AM by Michael Croft
    , NY - Feb 28, 2019 - Rare Disease Day - A unique non-profit and private partnership using a datathon and an AI-powered technology platform has identified five repurposable drug candidates to treat a painful chronic disease affecting about a million people globally and for which there is no current treatment
    Full story
  • TARGET PharmaSolutions® to Advance Dermatology Research, including Atopic Dermatitis, through New Collaboration

    Feb 27, 2019, 13:45 PM by Michael Croft
    DURHAM, NC - Feb 27, 2019 - TARGET PharmaSolutions, Inc., a real-world clinical data solutions company, is pleased to announce that Novartis Pharma AG is the first industry partner to provide multi-year support to TARGET-DERM registry TARGET-DERM is a global longitudinal observational study that evaluates adult and pediatric patients with immune-mediated inflammatory skin conditions (IMISCs)
    Full story
  • China Unveils New Rules On Biotech After Gene-Editing Scandal

    Feb 27, 2019, 10:08 AM by Michael Croft
    STAT | China has unveiled draft regulations on gene editing and other potentially risky biomedical technologies after a Chinese scientist's claim of helping to create gene-edited babies roiled the global science community.
    Full story
  • Illumina, VAST Data, Thermo Fisher Scientific, And More: News From February 2019

    Feb 27, 2019, 09:25 AM by Michael Croft

    Bio-IT World | February featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Illumina, VAST Data, Thermo Fisher Scientific, and more.

    Full story
  • MR Solutions’ high-field multi-modality, cryogen-free MRI system on display at EMIM

    Feb 27, 2019, 06:32 AM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Feb 27, 2019 - MR Solutions’ latest compact preclinical, multi-modality MRI systems will be on display at the 14th European Molecular Imaging Meeting (EMIM 2019) being held at the Scottish Event Campus in Glasgow on 19 to 22 March, 2019
    Full story
  • CRF Bracket Grows More in First Quarter Together than Either Company Achieved Alone in 2018

    Feb 27, 2019, 03:59 AM by Michael Croft
    PHILADELPHIA, PA - Feb 27, 2019 - CRF Bracket recently closed its first full quarter as a combined business after CRF Health and Bracket merged in September of 2018
    Full story
  • «
  • 241
  • 242
  • 243
  • 244
  • 245 (current)
  • 246
  • 247
  • 248
  • 249
  • 250
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy